CHSY1
CHSY1 (chondroitin sulfate synthase 1, also known as KIAA0990 or CSS1) is a Golgi glycosyltransferase with dual glucuronyltransferase and N-acetylgalactosaminyltransferase activity. It builds the chondroitin polymer that forms the backbone of chondroitin sulfate. Browse Assay Genie's current range of CHSY1 research reagents below, or read on for the biology behind the target.
CHSY1 is the catalytic component of the CHSY1-CHPF2 and CHSY1-CHPF chondroitin sulfate synthase complexes. It has both beta-1,3-glucuronic acid transferase and beta-1,4-N-acetylgalactosamine transferase activity. The enzyme transfers glucuronic acid (GlcUA) from UDP-GlcUA, and N-acetylgalactosamine (GalNAc) from UDP-GalNAc, to the non-reducing end of the elongating chondroitin polymer. Two sugar-transfer reactions in one protein allow the chain to be extended by alternating residues.
The CHSY1 gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family, and the protein is assigned to the beta 4-glycosyltransferase and beta 3-glycosyltransferase gene groups. UniProt lists its location as the Golgi stack membrane, with a secreted form also annotated. Researchers studying chondroitin sulfate biosynthesis, whether by CHSY1 antibody, CHSY1 ELISA kit or recombinant CHSY1 protein approaches, are working with an enzyme that acts in the Golgi apparatus.
Chondroitin sulfate is a glycosaminoglycan involved in many biological processes, including cell proliferation and morphogenesis. UniProt reports that CHSY1 is involved in the negative control of osteogenesis, likely through modulation of NOTCH signalling. Decreased expression of the gene may play a role in colorectal cancer, and mutations in CHSY1 are a cause of Temtamy preaxial brachydactyly syndrome. The protein was formerly named carbohydrate (chondroitin) synthase 1, and the mouse ortholog is Chsy1.
CHSY1 catalyses chain elongation of chondroitin, making it a core enzyme for studying how chondroitin sulfate backbones are assembled in the Golgi.
CHSY1 negatively controls osteogenesis, likely by modulating NOTCH signalling, so it is relevant to studies of bone formation and morphogenesis.
Decreased CHSY1 expression may play a role in colorectal cancer, which makes it a candidate for work on glycosaminoglycans in tumour biology.
Mutations in CHSY1 cause Temtamy preaxial brachydactyly syndrome, linking the gene to research on genetic limb and digit disorders.
CHSY1 is a catalytic component of chondroitin sulfate synthase complexes with CHPF2 or CHPF. It transfers glucuronic acid from UDP-GlcUA and N-acetylgalactosamine from UDP-GalNAc to the non-reducing end of the growing chondroitin chain, so it extends the chondroitin polymer.
CHSY1 is also known as KIAA0990 and CSS1. Its former HGNC name was carbohydrate (chondroitin) synthase 1, and UniProt lists it as chondroitin sulfate synthase 1. It carries two EC numbers, 2.4.1.175 and 2.4.1.226, reflecting its two transferase activities.
Mutations in the CHSY1 gene are a cause of Temtamy preaxial brachydactyly syndrome, and decreased expression may play a role in colorectal cancer. The mouse ortholog is Chsy1; check the datasheet of any product for its validated reactivity.
Chondroitin sulfate synthase partners, other glycosyltransferases and NOTCH pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q86X52; product specifications from Assay Genie datasheets.